At a glance
ClinicalIndex Comparison RecordPhase 2Completed· 167 enrolled
Drug / intervention
Standardized Allergenic Extract, Cat Hair +1 morebiological
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Dose-Ranging Study of Sublingual Immunotherapy (SLIT) in Adults Sensitized to the Standardized Allergenic Extract, Cat Hair (Felis Domesticus)
In Brief
A Phase 2 clinical trial evaluating Standardized Allergenic Extract, Cat Hair and Placebo for Allergy. Completed, enrolled 167 participants across 3 sites.
Detailed Summary
The purpose of this study is to identify an effective dose of allergen-specific immunotherapy for cat hair (Felis domesticus) administered by the oral/sublingual route.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsAllergy
CountriesUnited States
Collaborators--
Timeline
Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJun 2008
Enrollment StartOct 2008
Primary CompletionMay 2009
Study CompletionJun 2009
TodayJul 2026
First PostedJun 3, 2008
Enrollment StartOct 1, 2008
Primary CompletionMay 1, 2009
Study CompletionJun 1, 2009
TodayJul 2, 2026
Enrollment to primary: 7 monthsPosted 18.1 years ago
Interventions
Standardized Allergenic Extract, Cat Hairbiological
Standardized Cat Hair Allergenic Extract sublingual drops
Placebobiological
Placebo Sublingual Drops